Combination of sphingosine-1-phosphate receptor 1 (S1PR1) agonist and antiviral drug: a potential therapy against pathogenic influenza virus. [electronic resource]
Producer: 20201005Description: 5272 p. digitalISSN:- 2045-2322
- Administration, Intranasal
- Animals
- Antiviral Agents -- therapeutic use
- Blotting, Western
- Female
- Fluorescent Antibody Technique
- Indans -- therapeutic use
- Influenza A Virus, H1N1 Subtype -- pathogenicity
- Lung -- drug effects
- Male
- Mice
- Mice, Knockout
- Orthomyxoviridae Infections -- drug therapy
- Oseltamivir -- therapeutic use
- Oxadiazoles -- therapeutic use
- Real-Time Polymerase Chain Reaction
- Sphingosine-1-Phosphate Receptors -- agonists
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Retracted Publication
There are no comments on this title.
Log in to your account to post a comment.